FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients.
Wang Y, Tong Z, Zhang W, Zhang W, Buzdin A, Mu X, Yan Q, Zhao X, Chang HH, Duhon M, Zhou X, Zhao G, Chen H, Li X.
Wang Y, et al. Among authors: zhou x.
Front Oncol. 2021 Jun 7;11:683419. doi: 10.3389/fonc.2021.683419. eCollection 2021.
Front Oncol. 2021.
PMID: 34164344
Free PMC article.
Review.